Deep Brain Stimulators (DBS) - Medical Devices Pipeline Assessment, 2019

Table of Contents

• 1.1 List of Tables 6
• 1.2 List of Figures 10

2 Introduction 11

• 2.1 Deep Brain Stimulators (DBS) Overview 11

3 Products under Development 12

• 3.1 Deep Brain Stimulators (DBS) - Pipeline Products by Stage of Development 12
• 3.2 Deep Brain Stimulators (DBS) - Pipeline Products by Territory 13
• 3.3 Deep Brain Stimulators (DBS) - Pipeline Products by Regulatory Path 14
• 3.4 Deep Brain Stimulators (DBS) - Pipeline Products by Estimated Approval Date 15
• 3.5 Deep Brain Stimulators (DBS) - Ongoing Clinical Trials 16

4 Deep Brain Stimulators (DBS) - Pipeline Products under Development by Companies 17

• 4.1 Deep Brain Stimulators (DBS) Companies - Pipeline Products by Stage of Development 17
• 4.2 Deep Brain Stimulators (DBS) - Pipeline Products by Stage of Development 19

5 Deep Brain Stimulators (DBS) Companies and Product Overview 21

• 5.1 Adaptive Neuromodulation GmbH Company Overview 21
  • 5.1.1 Adaptive Neuromodulation GmbH Pipeline Products & Ongoing Clinical Trials Overview 21
• 5.2 Adept Neuro SA Company Overview 22
  • 5.2.1 Adept Neuro SA Pipeline Products & Ongoing Clinical Trials Overview 22
• 5.3 Aleva Neurotherapeutics SA Company Overview 23
  • 5.3.1 Aleva Neurotherapeutics SA Pipeline Products & Ongoing Clinical Trials Overview 23
• 5.4 Baylor College of Medicine Company Overview 24
  • 5.4.1 Baylor College of Medicine Pipeline Products & Ongoing Clinical Trials Overview 24
• 5.5 Bioinduction Limited Company Overview 25
  • 5.5.1 Bioinduction Limited Pipeline Products & Ongoing Clinical Trials Overview 25
• 5.6 Boston Scientific Corp Company Overview 28
  • 5.6.1 Boston Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview 28
• 5.7 Brainsway Ltd Company Overview 34
  • 5.7.1 Brainsway Ltd Pipeline Products & Ongoing Clinical Trials Overview 34
• 5.8 Cleveland Medical Devices Inc Company Overview 41
  • 5.8.1 Cleveland Medical Devices Inc Pipeline Products & Ongoing Clinical Trials Overview 41
• 5.9 Clinatec Company Overview 42
  • 5.9.1 Clinatec Pipeline Products & Ongoing Clinical Trials Overview 42
• 5.10 Cortera Neurotechnologies Inc Company Overview 43
  • 5.10.1 Cortera Neurotechnologies Inc Pipeline Products & Ongoing Clinical Trials Overview 43
• 5.11 Deep Brain Innovations, LLC Company Overview 44
  • 5.11.1 Deep Brain Innovations, LLC Pipeline Products & Ongoing Clinical Trials Overview 44
• 5.12 Enspire DBS Therapy Inc Company Overview 49
  • 5.12.1 Enspire DBS Therapy Inc Pipeline Products & Ongoing Clinical Trials Overview 49
• 5.13 Functional Neuromodulation Inc. Company Overview 52
  • 5.13.1 Functional Neuromodulation Inc. Pipeline Products & Ongoing Clinical Trials Overview 52
• 5.14 Louisiana State University Company Overview 57
  • 5.14.1 Louisiana State University Pipeline Products & Ongoing Clinical Trials Overview 57
• 5.15 Massachusetts General Hospital Company Overview 58
  • 5.15.1 Massachusetts General Hospital Pipeline Products & Ongoing Clinical Trials Overview 58
• 5.16 Massachusetts Institute of Technology Company Overview 60
  • 5.16.1 Massachusetts Institute of Technology Pipeline Products & Ongoing Clinical Trials Overview 60
• 5.17 Medtronic plc Company Overview 61
  • 5.17.1 Medtronic plc Pipeline Products & Ongoing Clinical Trials Overview 61
• 5.18 National Cheng-Kung University Hospital Company Overview 65
  • 5.18.1 National Cheng-Kung University Hospital Pipeline Products & Ongoing Clinical Trials Overview 65
• 5.19 NeuroOne Inc Company Overview 66
  • 5.19.1 NeuroOne Inc Pipeline Products & Ongoing Clinical Trials Overview 66
• 5.20 Neuroparticle Corp Company Overview 67
  • 5.20.1 Neuroparticle Corp Pipeline Products & Ongoing Clinical Trials Overview 67
• 5.21 NeuroPro Technologies Inc Company Overview 68
  • 5.21.1 NeuroPro Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview 68
• 5.22 Neurosigma Inc Company Overview 69
  • 5.22.1 Neurosigma Inc Pipeline Products & Ongoing Clinical Trials Overview 69
• 5.23 Newronika s.r.l. Company Overview 71
  • 5.23.1 Newronika s.r.l. Pipeline Products & Ongoing Clinical Trials Overview 71
• 5.24 Nexeon MedSystems Inc Company Overview 74
  • 5.24.1 Nexeon MedSystems Inc Pipeline Products & Ongoing Clinical Trials Overview 74
• 5.25 Sree Chitra Tirunal Institute for Medical Sciences & Technology Company Overview 76
  • 5.25.1 Sree Chitra Tirunal Institute for Medical Sciences & Technology Pipeline Products & Ongoing Clinical Trials Overview 76
• 5.26 St. Jude Medical LLC Company Overview 77
  • 5.26.1 St. Jude Medical LLC Pipeline Products & Ongoing Clinical Trials Overview 77
• 5.27 Sunnybrook Health Sciences Centre Company Overview 82
  • 5.27.1 Sunnybrook Health Sciences Centre Pipeline Products & Ongoing Clinical Trials Overview 82
• 5.28 SUNY Downstate Medical Center Company Overview 85
  • 5.28.1 SUNY Downstate Medical Center Pipeline Products & Ongoing Clinical Trials Overview 85
• 5.29 University of California Los Angeles Company Overview 86
  • 5.29.1 University of California Los Angeles Pipeline Products & Ongoing Clinical Trials Overview 86
• 5.30 University of Central Florida Company Overview 88
  • 5.30.1 University of Central Florida Pipeline Products & Ongoing Clinical Trials Overview 88
• 5.31 University of Florida Company Overview 89
  • 5.31.1 University of Florida Pipeline Products & Ongoing Clinical Trials Overview 89
• 5.32 University of Houston Company Overview 91
  • 5.32.1 University of Houston Pipeline Products & Ongoing Clinical Trials Overview 91
• 5.33 University of Illinois Company Overview 92
  • 5.33.1 University of Illinois Pipeline Products & Ongoing Clinical Trials Overview 92
• 5.34 University of Milan Company Overview 93
  • 5.34.1 University of Milan Pipeline Products & Ongoing Clinical Trials Overview 93
• 5.35 University of Minnesota Company Overview 94
  • 5.35.1 University of Minnesota Pipeline Products & Ongoing Clinical Trials Overview 94
• 5.36 University of Oxford Company Overview 95
  • 5.36.1 University of Oxford Pipeline Products & Ongoing Clinical Trials Overview 95
• 5.37 University of Rochester Company Overview 96
  • 5.37.1 University of Rochester Pipeline Products & Ongoing Clinical Trials Overview 96
• 5.38 University of South Florida Company Overview 97
  • 5.38.1 University of South Florida Pipeline Products & Ongoing Clinical Trials Overview 97
• 5.39 Wedge Therapeutics Company Overview 98
  • 5.39.1 Wedge Therapeutics Pipeline Products & Ongoing Clinical Trials Overview 98

6 Deep Brain Stimulators (DBS)- Recent Developments 99

• 6.1 Nov 25, 2019: BrainsWay reports third quarter 2019 financial results and operational highlights 99
• 6.2 Nov 25, 2019: BrainsWay appoints Medical Technology Industry Leader Christopher R. von Jako, Ph.D., as President and Chief Executive Officer 100
• 6.3 Nov 19, 2019: Medtronic reports second quarter financial results for the year 2019 101
• 6.4 Nov 14, 2019: Medtronic highlights leadership in inclusion, diversity, and equity in 2019 integrated performance report 103
• 6.5 Nov 12, 2019: TMS program hosts open house to introduce Deep Transcranial Magnetic Stimulation (Deep TMS) Helmet to treat major depressive disorder (MDD) and Obsessive-Compulsive Disorder (OCD) 104

7 Appendix 161

• 7.1 Methodology 161
• 7.2 About GlobalData 164
• 7.3 Contact Us 164